Exubera Launch Falls Back To Early Autumn
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer will roll out an education program for physicians and patients at the end of July and will launch the inhaled insulin in September.
You may also be interested in...
Pfizer’s Not Waiting To Exhale; Firm Takes Action By Terminating Exubera
After the inhaled insulin failed to gain traction, Pfizer also has decided to stop funding investment in a second generation device.
Pfizer’s Not Waiting To Exhale; Firm Takes Action By Terminating Exubera
After the inhaled insulin failed to gain traction, Pfizer also has decided to stop funding investment in a second generation device.
Lilly/Alkermes Broaden Inhaled Insulin Manufacturing Agreement
The update ensures adequate supplies of insulin powder “if and when” the AIR inhaled insulin system is launched, Lilly told “The Pink Sheet” DAILY.